Why is Venmax Drugs falling/rising?

As of 18-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 25.25, reflecting a rise of 1.2 or 4.99%. The stock has shown a trend reversal today, gaining after three consecutive days of decline. It opened with a gain of 4.99% and reached an intraday high of Rs 25.25. However, despite today's positive movement, the stock has underperformed over the past week and month, with declines of 3.11% and 10.78%, respectively. Year-to-date, the stock has performed well with a gain of 39.97%, indicating strong long-term performance. Notably, investor participation has decreased significantly, with delivery volume dropping by 94.01% compared to the five-day average, which may indicate caution among investors.
Broader market context shows that while Venmax has outperformed its sector today by 3.94%, it has lagged behind the Sensex in both the one-week and one-month periods. The Sensex has gained 1.80% over the past week and 2.14% over the past month, contrasting with Venmax's declines. This suggests that while the stock is experiencing a short-term rebound, its recent performance has not aligned with broader market trends. The stock's liquidity remains adequate for trading, but the significant drop in delivery volume could be a concern for future price stability.